Calyxt, Inc. Stock Nasdaq
Equities
CBUS
US17166A1016
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 2.17M | Sales 2025 * | 8.69M | Capitalization | 223M |
---|---|---|---|---|---|
Net income 2024 * | -82M | Net income 2025 * | -88M | EV / Sales 2024 * | 103 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 25.6 x |
P/E ratio 2024 * |
-3.39
x | P/E ratio 2025 * |
-4.4
x | Employees | 183 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.17% |
Latest transcript on Calyxt, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Wade King
DFI | Director of Finance/CFO | 67 | - |
Peter Beetham
PSD | President | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Mark Finn
BRD | Director/Board Member | 81 | - |
Keith Walker
BRD | Director/Board Member | 76 | - |
1st Jan change | Capi. | |
---|---|---|
+9.55% | 222B | |
+14.41% | 196B | |
+24.02% | 148B | |
+33.92% | 114B | |
+4.18% | 65.69B | |
+12.92% | 51.88B | |
+3.16% | 50.02B | |
-4.32% | 38.81B | |
-1.99% | 34.59B |